n Cardiovascular Journal of South Africa - Cardio news

Volume 16, Issue 3
  • ISSN : 1680-0745



Extracted from text ... 188 CARDIOVASCULAR JOURNAL OF SOUTH AFRICA Vol 16, No. 3, May/June 2005 Cardio News Patent court interdicts sale of Cipla-Medpro's Nortwin The judge of the High Court of South Africa ruled in favour of Pfizer Laboratories and interdicted Cipla-Medpro, preventing them from selling a generic of Norvasc(r) (amlodipine besylate). This court ruling followed on from a letter dated 28 January 2005, whereby Cipla-Medpro informed healthcare providers that it had been advised that Pfizer's patent 87/2439, in respect of amlodipine besylate, was invalid and not enforceable. Under the circumstances, Cipla-Medpro introduced their product into the market under the name Nortwin. Pfizer Ltd ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error